Arrayed CRISPR Screening for Revolutionizing Target Discovery

In this interview conducted at SLAS EU 2023 in Brussels, Belgium, we spoke to Ulrike Kuenzel, Associate Director in the Functional Genomics department at AstraZeneca about the application of arrayed CRISPR screening for target identification and more.

EC grants authorisation to LEO Pharma’s Anzupgo cream

The cream is indicated for use by chronic hand eczema patients for whom topical corticosteroids are not suitable. Credit: Ladanifer/Shutterstock. The European Commission (EC) has

September 24, 2024

Incyte drops four early-stage programs from its pipeline as part of strategic review

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 31, 2024

Bio-Thera, Biomm enter licensing deal for ustekinumab biosimilar

Bio-Thera’s BAT2206 is approved to treat moderate to severe plaque psoriasis patients aged six years or above. Credit: Ternavskaia Olga Alibec via shutterstock.com. Bio-Thera Solutions

June 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.